Atlas Trials

Essential Hypertension

Clinical trial NCT01264692 · COMPLETED

Trial details

NCT number
NCT01264692
Sponsor
Idorsia Pharmaceuticals Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2011-02-01
Primary completion
2012-01-01
Enrollment
196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.